REGENERON News & Analysis

These stocks could benefit from the race to roll out antibody therapy for covid-19, writes Vikram Barhat.

We expect most US adults will be vaccinated in the first half of 2021, writes Morningstar healthcare strategist Karen Andersen.

Three new vaccines for coronavirus look poised for emergency use authorisation in the US this autumn. What does that mean for investors?

The US is slowing the coronavirus spread as drug makers race toward a vaccine; while the longer-term economic effect will be modest, say Morningstar...